Search details
1.
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages.
Cell
; 184(11): 2988-3005.e16, 2021 05 27.
Article
in English
| MEDLINE | ID: mdl-34019793
2.
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy.
Prostate
; 80(4): 336-344, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31899823
3.
Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection.
Blood
; 122(3): 348-56, 2013 Jul 18.
Article
in English
| MEDLINE | ID: mdl-23673862
4.
A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control.
Cancer Immunol Immunother
; 63(11): 1163-76, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25082071
5.
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.
Eur Urol
; 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38782695
6.
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.
JCO Precis Oncol
; 8: e2300274, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38691813
7.
Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.
J Immunol
; 186(9): 5193-200, 2011 May 01.
Article
in English
| MEDLINE | ID: mdl-21451107
8.
Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance.
Clin Cancer Res
; 29(8): 1377-1380, 2023 04 14.
Article
in English
| MEDLINE | ID: mdl-36749325
9.
Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations.
Eur Urol
; 83(3): 195-199, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36344318
10.
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.
Eur Urol Oncol
; 2023 Nov 07.
Article
in English
| MEDLINE | ID: mdl-37945488
11.
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.
Clin Cancer Res
; 29(22): 4586-4595, 2023 11 14.
Article
in English
| MEDLINE | ID: mdl-37682528
12.
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
J Clin Oncol
; 40(21): 2333-2341, 2022 07 20.
Article
in English
| MEDLINE | ID: mdl-35298296
13.
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
J Clin Oncol
; 40(12): 1312-1322, 2022 04 20.
Article
in English
| MEDLINE | ID: mdl-35089812
14.
Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses.
Clin Cancer Res
; 27(2): 608-621, 2021 01 15.
Article
in English
| MEDLINE | ID: mdl-33148676
15.
Considerations for treatment duration in responders to immune checkpoint inhibitors.
J Immunother Cancer
; 9(3)2021 03.
Article
in English
| MEDLINE | ID: mdl-33653801
16.
Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.
Mol Immunol
; 46(5): 902-16, 2009 Feb.
Article
in English
| MEDLINE | ID: mdl-18962897
17.
Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting.
Clin Cancer Res
; 26(9): 2087-2095, 2020 05 01.
Article
in English
| MEDLINE | ID: mdl-31948999
18.
Lighting the torch: intratumoural T cell-to-stroma enrichment score as a predictor of immunotherapy response in urothelial carcinoma.
Nat Rev Clin Oncol
; 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38622410
19.
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide.
Semin Oncol
; 46(4-5): 351-361, 2019.
Article
in English
| MEDLINE | ID: mdl-31757478
20.
Engineering higher affinity T cell receptors using a T cell display system.
J Immunol Methods
; 339(2): 175-84, 2008 Dec 31.
Article
in English
| MEDLINE | ID: mdl-18854190